3.36
-0.59%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About YSB
Its shares trade on HKEX under the ticker 9885.HK. It has been listed since 28 June 2023. In the fiscal year to 31 December 2025, it reported revenue of CN¥24.42bn and net income of CN¥178.1m. At that date it held total assets of CN¥8.81bn and shareholders' equity of CN¥2.85bn.
YSB, Inc. is an investment holding company, which engages in the operation of online platforms. The company is headquartered in Guangzhou, Guangdong. The company went IPO on 2023-06-28. The firm is mainly engaged in the wholesale and retail of pharmaceuticals and healthcare products on offline or online platforms. The firm provides an online platform for pharmaceutical distributors to sell their pharmaceuticals and healthcare products. The firm also provides software-as-a-service (SaaS) solutions for pharmacies, provides medical testing services for primary medical institutions, sells smart unmanned pharmaceutical booth to third-party pharmacies, as well as provides maintenance and technical support services in relation to the smart unmanned pharmaceutical booth to third-party pharmacies. The firm principally conducts its businesses in the domestic market.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 28 Jun 2023
- Employees
- 6,108
- Website
- ysbang.cn ↗
Leadership
Pay as last reported
- Mr. Buzhen ZhangExecutive Chairman of the Board, Chief Executive Officer, since 2015CN¥1.7m
- Mr. Fei ChenChief Financial Officer, Executive Director, Joint Company Secretary, since 2022CN¥17.8m
- Mr. Haodong XiaoVice President
- Mr. Zhuoqi ChenDirector of Technology
- Ms. Emily FungJoint Company Secretary
- Mr. Ziyang ZhuNon-Executive Director
- Prof. Rong ShaoIndependent Non-Executive Director
- Mr. Hanhui SunIndependent Non-Executive Director
- Mr. Hongqiang ZhaoIndependent Non-Executive Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- YSB Inc's online platform connects pharmaceutical distributors with healthcare products efficiently.
- The company's SaaS solutions for pharmacies enhance operational efficiency in the Health Care sector.
- YSB Inc's smart unmanned pharmaceutical booths are a unique product in the domestic market.
Weaknesses
- YSB Inc's business is primarily limited to the domestic market in China.
- The company's IPO on 28 June 2023 indicates a relatively new market presence.
- YSB Inc's reliance on offline and online pharmaceutical wholesale and retail may face competition.
Opportunities
- Expanding into international markets could leverage YSB Inc's SaaS solutions for global pharmacies.
- Growing demand for smart unmanned pharmaceutical booths in China presents new opportunities.
- Increasing healthcare services in primary medical institutions can boost YSB Inc's medical testing services.
Threats
- Regulatory changes in China's Health Care sector could impact YSB Inc's operations.
- Competition from established pharmaceutical companies may challenge YSB Inc's market share.
- Economic downturns in China might reduce consumer spending on healthcare products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.